EastPharma is a pharmaceutical company specialising in the manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional markets.
EastPharma was established on 17 August 2006 and controls Deva Holding, one of Turkey’s leading pharmaceutical companies. In 2007, EastPharma acquired Saba Pharmaceuticals, a Turkish specialty pharma company, and conducted an IPO on the London Stock Exchange. Further, in 2008, EastPharma signed an In-licensing and Supply Agreement with F.Hoffman-La Roche for 16 products.
R&D continues its activities with the vision of becoming the top generic drug manufacturer of Turkey. It mainly develops products exportable to international markets and high quality affordable products.
CONTINUE
